A phase II study of BAY 43–9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal cancer (NPC)
暂无分享,去创建一个
G. Pond | L. Siu | O. Petrenciuc | E. Winquist | E. Chen | S. Chin | P. Francis | M. Agulnik | R. Cheiken